<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huang J</submitter><funding>Department of Health and Human Services</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>1721-1732</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6070082</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>187(8)</volume><pubmed_abstract>Tobacco use, hypertension, hyperglycemia, overweight, and inactivity are leading causes of overall and cardiovascular disease (CVD) mortality worldwide, yet the relevant metabolic alterations responsible are largely unknown. We conducted a serum metabolomic analysis of 620 men in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (1985-2013). During 28 years of follow-up, there were 435 deaths (197 CVD and 107 cancer). The analysis included 406 known metabolites measured with ultra-high-performance liquid chromatography/mass spectrometry-gas chromatography/mass spectrometry. We used Cox regression to estimate mortality hazard ratios for a 1-standard-deviation difference in metabolite signals. The strongest associations with overall mortality were N-acetylvaline (hazard ratio (HR) </pubmed_abstract><journal>American journal of epidemiology</journal><pubmed_title>Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort.</pubmed_title><pmcid>PMC6070082</pmcid><funding_grant_id>HHSN261201500005C</funding_grant_id><pubmed_authors>Sampson JN</pubmed_authors><pubmed_authors>Hua X</pubmed_authors><pubmed_authors>Mondul AM</pubmed_authors><pubmed_authors>Albanes D</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Liao LM</pubmed_authors><pubmed_authors>Gu F</pubmed_authors><pubmed_authors>Derkach A</pubmed_authors><pubmed_authors>Moore SC</pubmed_authors><pubmed_authors>Weinstein SJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort.</name><description>Tobacco use, hypertension, hyperglycemia, overweight, and inactivity are leading causes of overall and cardiovascular disease (CVD) mortality worldwide, yet the relevant metabolic alterations responsible are largely unknown. We conducted a serum metabolomic analysis of 620 men in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (1985-2013). During 28 years of follow-up, there were 435 deaths (197 CVD and 107 cancer). The analysis included 406 known metabolites measured with ultra-high-performance liquid chromatography/mass spectrometry-gas chromatography/mass spectrometry. We used Cox regression to estimate mortality hazard ratios for a 1-standard-deviation difference in metabolite signals. The strongest associations with overall mortality were N-acetylvaline (hazard ratio (HR) </description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Aug</publication><modification>2025-04-04T20:30:42.782Z</modification><creation>2019-08-07T07:01:40Z</creation></dates><accession>S-EPMC6070082</accession><cross_references><pubmed>29390044</pubmed><doi>10.1093/aje/kwy017</doi></cross_references></HashMap>